Form 4 for NMTC NEUROONE MEDICAL TECHNOLOGIES Corp
Accepted 2025-02-04 00:00:00 ET · period of report 2025-01-31 · accession 0001540354-25-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-04 | 2025-01-31 | NMTC | Rosa David A | CEO, Pres, Dir | F - Tax | $1.15 | -2,239 | 1.14M | -0.2% | -$2,575 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-31 | F | D | 2,239 | $1.15 | 1,135,072 | D | — | — |